Literature DB >> 11899292

Airway remodeling in the pathogenesis of asthma.

A M Vignola1, R Gagliardo, A Siena, G Chiappara, M R Bonsignore, J Bousquet, G Bonsignore.   

Abstract

Asthma is characterized by a chronic inflammatory process of the airways followed by healing, the end result of which is an altered structure referred to as airway remodeling. Although the mechanisms responsible for such structural alterations appear to be heterogeneous, it is likely that abnormal airway cell dedifferentiation, migration, and redifferentiation, together with changes in connective tissue deposition, contribute to the altered restitution of airway structure and function. This altered restitution is often seen as fibrosis and increased smooth muscle, mucus gland mass, and vessel area. As a consequence of these structural changes, the airway wall in asthma is usually characterized by increased thickness and markedly and permanently reduced airway caliber. These features may result in increased airflow resistance, particularly when there is bronchial contraction and bronchial hyperresponsiveness. The effect on airflow is compounded by increased mucus secretion and inflammatory exudate, which not only block the airway passages but also cause increased surface tension favoring airway closure.

Entities:  

Mesh:

Year:  2001        PMID: 11899292     DOI: 10.1007/s11882-001-0077-4

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  50 in total

Review 1.  Asthma. From bronchoconstriction to airways inflammation and remodeling.

Authors:  J Bousquet; P K Jeffery; W W Busse; M Johnson; A M Vignola
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

Review 2.  Asthma: a disease remodeling the airways.

Authors:  J Bousquet; P Chanez; J Y Lacoste; R White; P Vic; P Godard; F B Michel
Journal:  Allergy       Date:  1992-02       Impact factor: 13.146

Review 3.  Lung myofibroblasts.

Authors:  K O Leslie; J Mitchell; R Low
Journal:  Cell Motil Cytoskeleton       Date:  1992

4.  Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid.

Authors:  A Laitinen; A Altraja; M Kämpe; M Linden; I Virtanen; L A Laitinen
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

5.  Repeated allergen exposure of sensitized Brown-Norway rats induces airway cell DNA synthesis and remodelling.

Authors:  M Salmon; D A Walsh; H Koto; P J Barnes; K F Chung
Journal:  Eur Respir J       Date:  1999-09       Impact factor: 16.671

6.  Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids.

Authors:  R Lundgren; M Söderberg; P Hörstedt; R Stenling
Journal:  Eur Respir J       Date:  1988-12       Impact factor: 16.671

7.  Vascularity in asthmatic airways: relation to inhaled steroid dose.

Authors:  B E Orsida; X Li; B Hickey; F Thien; J W Wilson; E H Walters
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

8.  Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma.

Authors:  G Mautino; C Henriquet; C Gougat; A Le Cam; J M Dayer; J Bousquet; F Capony
Journal:  Lab Invest       Date:  1999-01       Impact factor: 5.662

9.  Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation.

Authors:  M Hoshino; Y Nakamura; J Sim; J Shimojo; S Isogai
Journal:  J Allergy Clin Immunol       Date:  1998-11       Impact factor: 10.793

10.  Clinical, physiological and radiological features of asthma with incomplete reversibility of airflow obstruction compared with those of COPD.

Authors:  L P Boulet; H Turcotte; C Hudon; G Carrier; F Maltais
Journal:  Can Respir J       Date:  1998 Jul-Aug       Impact factor: 2.409

View more
  7 in total

1.  An orderly retreat: Dedifferentiation is a regulated process.

Authors:  Mariko Katoh; Chad Shaw; Qikai Xu; Nancy Van Driessche; Takahiro Morio; Hidekazu Kuwayama; Shinji Obara; Hideko Urushihara; Yoshimasa Tanaka; Gad Shaulsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-21       Impact factor: 11.205

Review 2.  Asthma and athletes: therapy to compete.

Authors:  John M Weiler; Christine Malloy
Journal:  Clin Rev Allergy Immunol       Date:  2005-10       Impact factor: 8.667

3.  Hyaluronan stimulates ex vivo B lymphocyte chemotaxis and cytokine production in a murine model of fungal allergic asthma.

Authors:  Sumit Ghosh; Scott A Hoselton; Steve B Wanjara; Jennifer Carlson; James B McCarthy; Glenn P Dorsam; Jane M Schuh
Journal:  Immunobiology       Date:  2015-02-07       Impact factor: 3.144

4.  Corticosteroids and montelukast: effects on airway epithelial and human umbilical vein endothelial cells.

Authors:  K Andersson; E B Shebani; N Makeeva; G M Roomans; Z Servetnyk
Journal:  Lung       Date:  2010-01-16       Impact factor: 2.584

Review 5.  Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document.

Authors:  N G Papadopoulos; P Xepapadaki; P Mallia; G Brusselle; J-B Watelet; M Xatzipsalti; G Foteinos; C M van Drunen; W J Fokkens; C D'Ambrosio; S Bonini; A Bossios; Jan Lötvall; P van Cauwenberge; S T Holgate; G W Canonica; A Szczeklik; G Rohde; J Kimpen; A Pitkäranta; M Mäkelä; P Chanez; J Ring; S L Johnston
Journal:  Allergy       Date:  2007-02-27       Impact factor: 13.146

6.  IL-13 induces a bronchial epithelial phenotype that is profibrotic.

Authors:  Nikita K Malavia; Justin D Mih; Christopher B Raub; Bao T Dinh; Steven C George
Journal:  Respir Res       Date:  2008-03-18

7.  Biosignature for airway inflammation in a house dust mite-challenged murine model of allergic asthma.

Authors:  Hadeesha Piyadasa; Anthony Altieri; Sujata Basu; Jacquie Schwartz; Andrew J Halayko; Neeloffer Mookherjee
Journal:  Biol Open       Date:  2016-01-06       Impact factor: 2.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.